Daniel Janney
CIK: 0001198325
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Krystal Biotech, Inc.
Discretionary Trading P&L
Holdings
Transaction History (26 total)
- Sep 14, 2026KRYS
Krystal Biotech, Inc.
Award(A)DirectRestricted Stock Award
471 shares- - Sep 14, 2026KRYS
Krystal Biotech, Inc.
Award(A)DirectStock Option (Right to Buy)
1.2K shares- - Feb 27, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Indirect9.4K shares at avg. $275.45$2.6M - Feb 27, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Indirect2.4K shares at avg. $276.17$655K - Feb 26, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Indirect5.1K shares at avg. $275.28$1.4M - Feb 26, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Indirect2.6K shares at avg. $276.32$729K - Feb 25, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Indirect700 shares at avg. $275.00$193K - Feb 24, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct4K shares at avg. $268.97$1.1M - Feb 24, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct370 shares at avg. $269.83$100K - Feb 24, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct373 shares at avg. $271.09$101K - Feb 24, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Indirect62 shares at avg. $263.05$16K - Feb 24, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Indirect900 shares at avg. $264.60$238K - Feb 24, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Indirect1.6K shares at avg. $265.54$426K - Feb 24, 2026KRYS
Krystal Biotech, Inc.
Exercise(M)Direct37.9K shares at avg. $2.46$93K - Feb 24, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Indirect1.9K shares at avg. $267.37$506K - Feb 24, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Indirect1.7K shares at avg. $268.67$450K - Feb 24, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Indirect930 shares at avg. $269.50$251K - Feb 24, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Indirect2.4K shares at avg. $274.90$667K - Feb 24, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Indirect4.3K shares at avg. $266.62$1.2M - Feb 24, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct569 shares at avg. $262.91$150K - Feb 24, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct1.7K shares at avg. $264.12$458K - Feb 24, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct3.6K shares at avg. $265.08$943K - Feb 24, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct9K shares at avg. $266.18$2.4M - Feb 24, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct11.7K shares at avg. $266.97$3.1M - Feb 24, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct6.7K shares at avg. $268.04$1.8M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 14, 2026 | KRYS Krystal Biotech, Inc. | Award(A) Restricted Stock Award | 471 | - | - | Direct |
| Sep 14, 2026 | KRYS Krystal Biotech, Inc. | Award(A) Stock Option (Right to Buy) | 1,187 | - | - | Direct |
| Feb 27, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 9,430 | $275.45 | $2,597,481 | Indirect |
| Feb 27, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 2,373 | $276.17 | $655,343 | Indirect |
| Feb 26, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 5,103 | $275.28 | $1,404,760 | Indirect |
| Feb 26, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 2,638 | $276.32 | $728,919 | Indirect |
| Feb 25, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 700 | $275.00 | $192,500 | Indirect |
| Feb 24, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 3,963 | $268.97 | $1,065,924 | Direct |
| Feb 24, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 370 | $269.83 | $99,836 | Direct |
| Feb 24, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 373 | $271.09 | $101,118 | Direct |
| Feb 24, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 62 | $263.05 | $16,309 | Indirect |
| Feb 24, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 900 | $264.60 | $238,136 | Indirect |
| Feb 24, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 1,604 | $265.54 | $425,919 | Indirect |
| Feb 24, 2026 | KRYS Krystal Biotech, Inc. | Exercise(M) | 37,895 | $2.46 | $93,222 | Direct |
| Feb 24, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 1,891 | $267.37 | $505,597 | Indirect |
| Feb 24, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 1,674 | $268.67 | $449,747 | Indirect |
| Feb 24, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 930 | $269.50 | $250,636 | Indirect |
| Feb 24, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 2,425 | $274.90 | $666,627 | Indirect |
| Feb 24, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 4,339 | $266.62 | $1,156,879 | Indirect |
| Feb 24, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 569 | $262.91 | $149,594 | Direct |
| Feb 24, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 1,733 | $264.12 | $457,728 | Direct |
| Feb 24, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 3,557 | $265.08 | $942,878 | Direct |
| Feb 24, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 8,986 | $266.18 | $2,391,885 | Direct |
| Feb 24, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 11,673 | $266.97 | $3,116,310 | Direct |
| Feb 24, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 6,671 | $268.04 | $1,788,079 | Direct |
1-25 of 26 transactions
About JANNEY DANIEL
JANNEY DANIEL (SEC CIK 0001198325) files insider reports with the SEC as Director of Krystal Biotech, Inc. (KRYS).
Signal8 holds 4 ownership filings by JANNEY DANIEL, all Form 4s, filed between Jun 30, 2025 and Sep 16, 2026. Those filings report 26 transactions, from Jun 30, 2025 to Sep 14, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on JANNEY DANIEL's filings is in PITTSBURGH, PA.
Recent filings by JANNEY DANIEL
- Sep 14, 2026: Grants or awards of KRYS derivative securities (2 lines, Form 4, code A).
- Feb 27, 2026: Open-market sales of KRYS shares (2 lines, Form 4, code S).
- Feb 26, 2026: Open-market sales of KRYS shares (2 lines, Form 4, code S).
- Feb 25, 2026: Open-market sale of KRYS shares (Form 4, code S).
- Feb 24, 2026: Open-market sales of KRYS shares (6 lines, Form 4, code S).
Other insiders filing for Krystal Biotech, Inc. (KRYS)
- ROSSI DINO A, Director
- Sutherland Everett Rand, Director
- Mazzacco Catherine, Director
- Mason Christopher, Director
- Gangolli Julian S, Director
- Krishnan Suma, President, R&D